All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

41

Reset

41 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IRP101meta-fluorobenzylguanidine, 18F-MFBGPhase 34 trials

    Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy

  • buntanetapposiphenPhase 33 trials

    Annovis Bio Inc. · Early Alzheimers Disease, Alzheimer's Dementia (AD), Parkinson's Disease (PD)

  • PrasinezumabRO7046015, PRX002Phase 33 trials

    Roche (Genentech) · Parkinson's Disease, Parkinsons Disease

  • RadotinibSupect, IY5511Phase 33 trials

    Il-Yang Pharm. Co., Ltd. · Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory

  • TJ0113Phase 33 trials

    Hangzhou PhecdaMed Co., Ltd. · Sarcopenia, Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset

  • AMX0035Phase 32 trials

    Amylyx Pharmaceuticals Inc. · Wolfram Syndrome, Progressive Supranuclear Palsy, PSP

  • CVN424Phase 32 trials

    Cerevance · Parkinson Disease, Parkinson's Disease

  • GM1Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Chemotherapy-induced Peripheral Neuropathy (CIPN), Parkinson's Disease

  • ONO-2808Phase 32 trials

    Ono Pharmaceutical Co., Ltd. · Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy (MSA)

  • bemdaneprocelMSK-DA01, BRT-DA01Phase 31 trial

    BlueRock Therapeutics · Parkinsons Disease (PD)

  • BHV-8000Phase 31 trial

    Biohaven Therapeutics Ltd. · Parkinson Disease

  • VG081821ACVG081821Phase 31 trial

    Zhejiang Vimgreen Pharmaceuticals, Ltd. · Parkinson Disease (PD)

  • Human Dopaminergic Progenitor CellsNouvNeu001Phase 23 trials

    iRegene Therapeutics Co., Ltd. · Parkinson Disease, Parkinson Disease (PD)

  • iPSChuman allogeneic induced pluripotent stem cell -derived dopaminergic neural progenitor cell, Allogeneic Human Induced Pluripotent Stem Cell -Derived Motor Neuron Progenitor CellsPhase 23 trials

    XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Spinal Cord Injury, Safety, Efficacy

  • AB-1005Phase 22 trials

    AskBio Inc · PARKINSON DISEASE (Disorder), Parkinson Disease

  • DNL151BIIB122Phase 22 trials

    Denali Therapeutics Inc. · Parkinson Disease

  • HBI-002Phase 22 trials

    Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell

  • NE3107bezisterimPhase 22 trials

    BioVie Inc. · Long COVID, Parkinsons Disease (PD)

  • RO7568282Phase 22 trials

    Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease

  • VIM0423Phase 22 trials

    Vima Therapeutics · PARKINSON DISEASE (Disorder), Dystonia

  • VTX3232Phase 22 trials

    Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity

  • VutiglabridinHSG4112Phase 22 trials

    Glaceum · Knee Osteoarthritis (Knee OA), Parkinson Disease

  • AP-472Phase 21 trial

    Appello Pharmaceuticals, Inc. · Parkinson Disease

  • ATR 1072Phase 21 trial

    Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic

  • BIA 28-6156Phase 21 trial

    Bial R&D Investments, S.A. · Parkinson's Disease

  • CPL500036Phase 21 trial

    Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced

  • EC5026Phase 21 trial

    EicOsis Human Health Inc. · Parkinson's Disease (PD)

  • exidavnemabPhase 21 trial

    BioArctic AB · Parkinson Disease, Multiple System Atrophy

  • GT-02287GT-02287 400, GT-02287 800Phase 21 trial

    Gain Therapeutics, Inc. · Parkinson Disease

  • IRL757Phase 21 trial

    Integrative Research Laboratories AB · PARKINSON DISEASE (Disorder), Apathy, Safety

  • KDT-3594Phase 21 trial

    Kissei Pharmaceutical Co., Ltd. · Parkinson Disease

  • LY3884961Phase 21 trial

    Prevail Therapeutics · Parkinson Disease

  • MT101-5Phase 21 trial

    Mthera Pharma Co., Ltd. · Parkinson's Disease

  • ND0612ND0612HPhase 21 trial

    NeuroDerm Ltd. · Parkinson's Disease

  • NEU-411Phase 21 trial

    Neuron23 Inc. · Parkinson Disease, Parkinson, Idiopathic Parkinson Disease

  • NYX-458Phase 21 trial

    Aptinyx · Mild Cognitive Impairment, Mild Dementia, Parkinson Disease

  • RNDP-001Phase 21 trial

    Kenai Therapeutics · Idiopathic Parkinson´s Disease, Parkinson's Disease

  • SUL-238t.i.d.Phase 21 trial

    GEN İlaç ve Sağlık Ürünleri A.Ş. · Parkinson's Disease (PD)

  • TB006Phase 21 trial

    TrueBinding, Inc. · Parkinson's Disease (PD)

  • UCB0022Phase 21 trial

    UCB · Parkinson Disease

  • XJN010Phase 21 trial

    Guangzhou Novaken Pharm Co., Ltd. · Parkinson Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.